Fate Therapeutics Growth Metrics (2012-2025) | FATE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.09M	0.01M	0.05M	-0.01M	0.00M	-338.00	-0.03M	0.03M	0.03M	-0.52M	-0.18M	-0.25M	-0.25M	0.51M	0.08M	-0.02M	0.02M	-0.12M	-0.03M	0.05M
EBITDA Margin Growth (3y) (Quarter)	0.10M	0.15M	0.13M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.51M	-0.15M	-0.23M	-0.21M	-0.02M	-0.12M	-0.24M	-0.19M	-0.14M	-0.13M	-0.22M
EBITDA Margin Growth (5y) (Quarter)	0.02M	0.04M	0.05M	0.04M	0.06M	0.05M	0.05M	0.11M	0.13M	-0.37M	-0.07M	-0.16M	-0.18M	0.03M	-0.04M	-0.18M	-0.10M	-0.13M	-0.11M	-0.20M
EBITDA Margin (QoQ) (Quarter)	-0.01M	-214.00	0.01M	-0.01M	0.00M	-0.00M	-0.01M	0.04M	0.01M	-0.56M	0.33M	-0.03M	0.01M	0.19M	-0.09M	-0.13M	0.05M	0.05M	-0.01M	-0.05M
EBIT Margin Growth (1y) (Quarter)	0.10M	0.02M	0.00M	-0.02M	0.00M	-0.01M	-0.02M	0.03M	0.04M	-0.63M	-0.21M	-0.27M	-0.26M	0.60M	0.09M	-0.05M	0.01M	-0.13M	-0.03M	0.08M
EBIT Margin Growth (3y) (Quarter)	0.10M	0.16M	0.12M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.62M	-0.22M	-0.27M	-0.22M	-0.03M	-0.13M	-0.29M	-0.21M	-0.15M	-0.14M	-0.24M
EBIT Margin Growth (5y) (Quarter)	0.02M	0.04M	0.04M	0.03M	0.06M	0.05M	0.04M	0.10M	0.13M	-0.48M	-0.10M	-0.19M	-0.19M	0.02M	-0.06M	-0.23M	-0.12M	-0.14M	-0.16M	-0.23M
EBIT Margin (QoQ) (Quarter)	-0.02M	0.01M	-0.00M	-0.00M	208.00	-0.00M	-0.01M	0.04M	0.01M	-0.67M	0.41M	-0.02M	0.02M	0.20M	-0.10M	-0.16M	0.08M	0.06M	-0.01M	-0.05M
EBT Margin Growth (1y) (Quarter)	0.09M	0.02M	0.00M	-0.02M	922.00	-0.01M	-0.02M	0.03M	0.04M	-0.58M	-0.18M	-0.25M	-0.24M	0.56M	0.08M	-0.05M	0.01M	-0.12M	-0.03M	0.07M
EBT Margin Growth (3y) (Quarter)	0.10M	0.16M	0.13M	0.06M	0.03M	0.04M	0.05M	0.09M	0.13M	-0.57M	-0.20M	-0.24M	-0.20M	-0.02M	-0.12M	-0.27M	-0.19M	-0.13M	-0.13M	-0.22M
EBT Margin Growth (5y) (Quarter)	0.02M	0.05M	0.05M	0.04M	0.06M	0.05M	0.05M	0.11M	0.13M	-0.43M	-0.08M	-0.16M	-0.17M	0.02M	-0.05M	-0.21M	-0.10M	-0.13M	-0.14M	-0.22M
EBT Margin (QoQ) (Quarter)	-0.02M	0.01M	-0.00M	-0.00M	261.00	-0.00M	-0.01M	0.04M	0.01M	-0.62M	0.38M	-0.02M	0.02M	0.18M	-0.10M	-0.16M	0.08M	0.05M	-0.01M	-0.05M
Enterprise Value Growth (1y) (Quarter)	-288.69%	-30.41%	-38.85%	-27.54%	27.38%	18.22%	25.57%	29.17%	28.74%	33.56%	30.76%	27.75%	6.20%	19.33%	15.10%	11.46%	37.31%	26.91%	27.45%	27.02%
Enterprise Value Growth (3y) (Quarter)	-107.35%	-107.36%	-47.57%	-45.25%	-46.35%	-51.99%	-18.60%	-25.36%	-26.23%	10.85%	10.56%	13.26%	21.41%	24.04%	24.09%	23.19%	25.17%	26.83%	24.73%	22.42%
Enterprise Value Growth (5y) (Quarter)	-70.02%	-72.21%	-70.85%	-46.23%	-47.46%	-51.61%	-48.81%	-34.01%	-35.77%	-37.10%	-10.61%	-9.41%	-15.95%	-13.48%	0.39%	-4.74%	-3.41%	16.02%	15.11%	15.86%
Enterprise Value (QoQ) (Quarter)	-63.62%	11.96%	2.43%	9.25%	6.84%	0.86%	11.20%	13.64%	6.26%	7.57%	7.46%	9.88%	-21.69%	20.51%	2.61%	6.01%	13.85%	7.32%	3.32%	5.46%
FCF Margin Growth (1y) (Quarter)	0.08M	-0.09M	-0.00M	-0.01M	-0.01M	-962.00	0.01M	232.00	0.04M	-0.30M	-0.16M	-0.16M	-0.17M	0.28M	0.10M	0.03M	-0.04M	-0.09M	-0.03M	-0.06M
FCF Margin Growth (3y) (Quarter)	0.10M	0.09M	-0.00M	0.05M	0.03M	0.05M	0.04M	0.07M	0.10M	-0.40M	-0.16M	-0.17M	-0.15M	-0.02M	-0.05M	-0.13M	-0.17M	-0.11M	-0.09M	-0.19M
FCF Margin Growth (5y) (Quarter)	0.03M	0.05M	0.03M	0.05M	0.03M	0.07M	0.06M	0.07M	0.12M	-0.21M	-0.16M	-0.11M	-0.10M	0.02M	-0.01M	-0.06M	-0.10M	-0.21M	-0.09M	-0.20M
FCF Margin (QoQ) (Quarter)	-0.01M	0.00M	-0.02M	0.02M	-0.02M	0.02M	-0.01M	0.01M	0.02M	-0.32M	0.13M	0.02M	0.01M	0.13M	-0.05M	-0.06M	-0.06M	0.07M	0.01M	-0.08M
Interest Coverage Ratio Growth (1y) (Quarter)
Interest Coverage Ratio Growth (3y) (Quarter)
Interest Coverage Ratio Growth (5y) (Quarter)
Interest Coverage Ratio (QoQ) (Quarter)
Net Margin Growth (1y) (Quarter)	0.09M	0.02M	0.00M	-0.02M	922.00	-0.01M	-0.02M	0.03M	0.04M	-0.58M	-0.18M	-0.25M	-0.24M	0.56M	0.08M	-0.05M	0.01M	-0.12M	-0.03M	0.07M
Net Margin Growth (3y) (Quarter)	0.10M	0.16M	0.13M	0.06M	0.03M	0.04M	0.05M	0.09M	0.13M	-0.57M	-0.20M	-0.24M	-0.20M	-0.02M	-0.12M	-0.27M	-0.19M	-0.13M	-0.13M	-0.22M
Net Margin Growth (5y) (Quarter)	0.02M	0.05M	0.05M	0.04M	0.06M	0.05M	0.05M	0.11M	0.13M	-0.43M	-0.08M	-0.16M	-0.17M	0.02M	-0.05M	-0.21M	-0.10M	-0.13M	-0.14M	-0.22M
Net Margin (QoQ) (Quarter)	-0.02M	0.01M	-0.00M	-0.00M	261.00	-0.00M	-0.01M	0.04M	0.01M	-0.62M	0.38M	-0.02M	0.02M	0.18M	-0.10M	-0.16M	0.08M	0.05M	-0.01M	-0.05M
Operating Margin Growth (1y) (Quarter)	0.10M	0.02M	0.00M	-0.02M	0.00M	-0.01M	-0.02M	0.03M	0.04M	-0.63M	-0.21M	-0.27M	-0.26M	0.60M	0.09M	-0.05M	0.01M	-0.13M	-0.03M	0.08M
Operating Margin Growth (3y) (Quarter)	0.10M	0.16M	0.12M	0.06M	0.04M	0.04M	0.05M	0.09M	0.13M	-0.62M	-0.22M	-0.27M	-0.22M	-0.03M	-0.13M	-0.29M	-0.21M	-0.15M	-0.14M	-0.24M
Operating Margin Growth (5y) (Quarter)	0.02M	0.04M	0.04M	0.03M	0.06M	0.05M	0.04M	0.10M	0.13M	-0.48M	-0.10M	-0.19M	-0.19M	0.02M	-0.06M	-0.23M	-0.12M	-0.14M	-0.16M	-0.23M
Operating Margin (QoQ) (Quarter)	-0.02M	0.01M	-0.00M	-0.00M	208.00	-0.00M	-0.01M	0.04M	0.01M	-0.67M	0.41M	-0.02M	0.02M	0.20M	-0.10M	-0.16M	0.08M	0.06M	-0.01M	-0.05M
Return on Assets Growth (1y) (Quarter)	19.00	9.00	1.00	-3.00	-11.00	-18.00	-22.00	-19.00	-11.00	-4.00	6.00	9.00	2.00	5.00	-1.00	-8.00	-8.00	-14.00	-10.00	0.00M
Return on Assets Growth (3y) (Quarter)	31.00	49.00	24.00	8.00	6.00	3.00	-8.00	-11.00	-2.00	-14.00	-15.00	-13.00	-20.00	-17.00	-17.00	-19.00	-16.00	-13.00	-5.00	0.00M
Return on Assets Growth (5y) (Quarter)	20.00	29.00	34.00	24.00	12.00	12.00	12.00	7.00	9.00	27.00	8.00	-2.00	-3.00	4.00	-3.00	-11.00	-8.00	-22.00	-26.00	-21.00
Return on Assets (QoQ) (Quarter)	4.00	1.00	-3.00	-5.00	-5.00	-6.00	-6.00	-2.00	4.00	0.00M	4.00	1.00	-3.00	4.00	-3.00	-6.00	-3.00	-2.00	1.00	4.00
Return on Capital Employed Growth (1y) (Quarter)	21.00	10.00	1.00	-1.00	-11.00	-21.00	-27.00	-25.00	-12.00	-5.00	7.00	11.00	-1.00	5.00	-2.00	-10.00	-8.00	-16.00	-12.00	-1.00
Return on Capital Employed Growth (3y) (Quarter)	34.00	61.00	29.00	11.00	9.00	5.00	-8.00	-16.00	-2.00	-16.00	-18.00	-15.00	-24.00	-21.00	-22.00	-24.00	-21.00	-16.00	-7.00	0.00M
Return on Capital Employed Growth (5y) (Quarter)	39.00	57.00	69.00	31.00	16.00	12.00	13.00	4.00	11.00	35.00	9.00	-4.00	-4.00	5.00	-3.00	-15.00	-11.00	-27.00	-32.00	-26.00
Return on Capital Employed (QoQ) (Quarter)	5.00	2.00	-3.00	-5.00	-5.00	-8.00	-8.00	-4.00	8.00	-1.00	3.00	0.00M	-4.00	5.00	-3.00	-8.00	-2.00	-3.00	1.00	3.00
Return on Equity Growth (1y) (Quarter)	25.00	13.00	3.00	0.00M	-14.00	-26.00	-32.00	-30.00	-16.00	-4.00	11.00	15.00	4.00	7.00	-2.00	-12.00	-11.00	-22.00	-18.00	-5.00
Return on Equity Growth (3y) (Quarter)	42.00	77.00	32.00	9.00	10.00	10.00	-13.00	-22.00	-4.00	-16.00	-19.00	-14.00	-26.00	-23.00	-23.00	-26.00	-23.00	-19.00	-9.00	-2.00
Return on Equity Growth (5y) (Quarter)	44.00	67.00	81.00	37.00	14.00	15.00	19.00	9.00	13.00	47.00	10.00	-5.00	-2.00	13.00	-4.00	-18.00	-12.00	-31.00	-38.00	-31.00
Return on Equity (QoQ) (Quarter)	8.00	3.00	-4.00	-6.00	-7.00	-9.00	-10.00	-4.00	8.00	3.00	5.00	1.00	-4.00	6.00	-4.00	-10.00	-4.00	-4.00	-1.00	3.00
Return on Sales Growth (1y) (Quarter)	921.00	167.00	29.00	-197.00	9.00	-98.00	-183.00	266.00	360.00	-0.01M	-0.00M	-0.00M	-0.00M	0.01M	837.00	-506.00	108.00	-0.00M	-288.00	737.00
Return on Sales Growth (3y) (Quarter)	966.00	0.00M	0.00M	560.00	349.00	389.00	531.00	874.00	0.00M	-0.01M	-0.00M	-0.00M	-0.00M	-248.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Sales Growth (5y) (Quarter)	222.00	469.00	470.00	368.00	584.00	496.00	465.00	0.00M	0.00M	-0.00M	-761.00	-0.00M	-0.00M	239.00	-464.00	-0.00M	-996.00	-0.00M	-0.00M	-0.00M
Return on Sales (QoQ) (Quarter)	-203.00	65.00	-36.00	-23.00	3.00	-42.00	-121.00	426.00	97.00	-0.01M	0.00M	-209.00	168.00	0.00M	-965.00	-0.00M	782.00	544.00	-62.00	-527.00

Research Tools

Fate Therapeutics Growth Metrics (2012-2025) | FATE

Create an account

Sign In

Reset Password